alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Exhibit
32.1




CERTIFICATION
PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE
SARBANES-OXLEY ACT OF 2002





In
connection with the Quarterly Report of Pharma-Bio Serv, Inc. (the "Company") on
Form 10-Q for the period ending January 31, 2009 as filed with the Securities
and Exchange Commission on the date hereof (the "Report"), Elizabeth Plaza,
Chief Executive Officer of the Company, and Pedro J. Lasanta, Chief Financial
Officer  of the Company, each certify, pursuant to 18 U.S.C. 1350, as
adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my
knowledge:





1. The
Report fully complies with the requirements of section 13(a) or 15(d) of the
Securities Exchange Act of 1934, as amended; and





2. The
information contained in the Report fairly presents, in all material respects,
the financial condition and result of operations of the Company.





Dated:
March 17, 2009





/s/
      Elizabeth Plaza
                  
                  /s/
      Pedro J. LasantaElizabeth
      Plaza
                  
                  Pedro
      J. LasantaChief
      Executive Officer
                  
                  Chief
      Financial
Officer
##### 



Exhibit 3.7
  www.state.oh.us/sos
 J. Kenneth Blackwell
 Expected this Form:(Select one)oYes
    
    PO Box 1300Columbus, OH 43216Requires an additional
fee of $100oNo
    
    PO Box 1028Columbus, OH 43216
   Certificate
of Amendment by
Shareholders or Members(Domestic)
Filing Fee $50.00
 (CHECK ONLY ONE (1) BOX)
 (1) Domestic for Profit
    
    
    
    
    
    (2) Domestic Non-Profitþ
Amended
    
    o
    
    Amendment
    
    o
    
    Amended
    
    o
    
    Amendment(122-AMAP)
    
    
    
    (125-AMDS)
    
    
    
    (128-AMAN)
    
    
    
    (128-AMD)
  Complete
the general information in this section for the box checklist
above.
 Name of Corporation
    
    Delton Corporation, Stryker Machining Facility Co.Charter Number
    
    738408Name
of Officer
    
    Gary W. LaCheyTitle
    
    Corporate Vice President  Finance, Treasurer,Secretary and Chief Financial Officer
 o
 A
meeting of the
    
    o     Shareholders
    

o     directors
(non-profit amended articles only)
 o members
was duly called and held on
    
    (Date)
  þ þ o (non profit amended articles only)
 o
    
    members who would be entitled to the notice of a meeting or such other proportion not less then a
majority as the articles of regulations or bylaws permit.
  Clause
applies if amended box is checked.
  Page 1 of 2




---



##### 



FIRST
    
    The name of the corporation is:
    
    Dalton Corporation,
Stryker Machining Facility Co.SECOND
    
    The place in the State of Ohio where its principal office is located is in the City of:Stryker

(city, village or township)
    
    Williams

                                (county)THIRD
    
    The purposes of the
corporation are as follows:The purpose for which the Corporation is formed is to engage in
any lawfull act or activity for which corporations may be formed under Section
1701.01 to 1701.98, inclusive of the Ohio Revised Code (the Code). The
Corporation shall have the power to do all things necessary or convenient to
carry out its business and affairs to the extent  such acts are permitted under
the Code.
 FOURTH
    
    The number of shares which the corporation is authorized to have outstanding is:
    

    1,000
 REQUIREDMust be authenticated
    
    /s/ William M. Barrett
    
    October 30, 2006(signed) by an authorized 
representative
    
    Authorized Representative
    
    Date(See instructions)
    
    William M.
Barrett(Print Name)President and Chief Executive Officer/s/ Gary W. Lachey
    
    October 30, 2006Authorized Representative
    
    DateGary W.
Lachey(Print Name)Corporate
Vice-President - Finance, Treasurer,Secretary and Chief Financial Officer
  Page 2 of 2
Exhibit 21.1
**PEGASUS SOLUTIONS, INC.**
**SUBSIDIARIES OF THE COMPANY**
The following is a list of subsidiaries of the Company as of December 31, 2004.   **            Name of Subsidiary** **Jurisdiction of Organization**   Anasazi Travel Resources KK JapanPegasus Business Intelligence, LP DelawarePegasus GP, LLC DelawarePegasus No. 1, LLC DelawarePegasus Solutions Australia Pty Ltd AustraliaPegasus Solutions Companies DelawarePegasus Solutions GmbH GermanyPegasus Solutions (Italy) Srl ItalyPegasus Solutions Limited United KingdomPegasus Solutions Mexico S.A. de C.V. MexicoPegasus Solutions (Singapore) Pte. Ltd. SingaporePegasus Solutions Spain, S.L. SpainPegSol Limited United KingdomPegsTour Limited United KingdomUnirez, LP DelawareUtell International do Brasil Turismo Ltda BrazilUtell India Private Limited IndiaUtell International United KingdomUtell International Colombia Ltda Republic of ColombiaUtell International Korea Ltd. KoreaUtell International (U.K.) Limited United KingdomUtell International (Thailand) Ltd. ThailandUtell Pension Trustees Limited United KingdomUtell Spain, S.L., Sociedad Unipersonal Spain
EXHIBIT 32.2

      CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT
                 TOSECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report on Form 10-QSB of Optionable,  Inc. (the
"Company")  for the  quarter  ended  September  30,  2007,  as  filed  with  the
Securities  and  Exchange  Commission  on the date  hereof (the  "Report"),  the
undersigned hereby certifies, pursuant to 18 U.S.C. Section 1350, to the best of
the undersigned's knowledge and belief, that:

          (1)  The Report fully complies with the  requirements of Section 13(a)
               or 15(d) of the Securities Exchange Act of 1934; and

          (2)  The information  contained in the Report fairly presents,  in all
               material  respects,   the  financial  condition  and  results  of
               operations of the Company.


                    Date:  November 13, 2007

                                        /s/Marc-Andre Boisseau
                                        -----------------------
                                        Marc-Andre Boisseau
                                        Chief Financial Officer



[A signed  original of this written  statement  required by Section 906 has been
provided  to  Optionable,  Inc.  and will be retained by  Optionable,  Inc.  and
furnished to the Securities and Exchange Commission or its staff upon request.]
STATE of Louisiana v. Malik GRAY

NO. 2019-KD-0918

Supreme Court of Louisiana.

June 6, 2019

Stay denied; writ denied.
Daniel LEIJA, Appellant, v. STATE of Florida, Appellee.

Case No. 5D18-373

District Court of Appeal of Florida, Fifth District.

Decision filed April 30, 2019

**FLORIDA DECISION WITHOUT PUBLISHED OPINION.**

AFFIRMED.
```

[Congressional Bills 117th Congress]
[From the U.S. Government Publishing Office]
[S.J. Res. 9 Placed on Calendar Senate (PCS)]

<DOC>

                                                        Calendar No.  8
117th CONGRESS
  1st Session
S. J. RES. 9

  Proposing an amendment to the Constitution of the United States to 
require that the Supreme Court of the United States be composed of nine 
                               justices.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                           February 25, 2021

 Mr. Cruz (for himself, Mr. Wicker, Mrs. Hyde-Smith, Mr. Marshall, Mr. 
Boozman, Mr. Hagerty, Mr. Cassidy, Mr. Lee, Mr. Portman, Mr. Grassley, 
  Mrs. Blackburn, Mr. Cotton, Ms. Ernst, Mr. Daines, Mr. Kennedy, Mr. 
 Barrasso, Mr. Inhofe, and Mr. Tillis) introduced the following joint 
               resolution; which was read the first time

                             March 1, 2021

            Read the second time and placed on the calendar

_______________________________________________________________________

                            JOINT RESOLUTION

 
  Proposing an amendment to the Constitution of the United States to 
require that the Supreme Court of the United States be composed of nine 
                               justices.

    Resolved by the Senate and House of Representatives of the United 
States of America in Congress assembled   (two-thirds of each House 
concurring therein), That the following article is proposed as an 
amendment to the Constitution of the United States, which shall be 
valid to all intents and purposes as part of the Constitution when 
ratified by the legislatures of three-fourths of the several States 
within seven years after the date of its submission for ratification:

                              ``Article--

    ``The Supreme Court of the United States shall be composed of nine 
justices.''.

                                                        Calendar No.  8

117th CONGRESS

  1st Session

                              S. J. RES. 9

_______________________________________________________________________

                            JOINT RESOLUTION

  Proposing an amendment to the Constitution of the United States to 
require that the Supreme Court of the United States be composed of nine 
                               justices.

_______________________________________________________________________

                             March 1, 2021

            Read the second time and placed on the calendar
```
Exhibit 32



CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE
SARBANES-OXLEY ACT OF 2002



I, Daniel C. Montano, certify, pursuant to 18
U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report of CardioVascular BioTherapeutics, Inc. on Form 10-Q for the period ended September 30, 2005 fully complies with the
requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in such Quarterly Report on Form 10-Q fairly presents in all material respects the financial condition and results of operations of
CardioVascular BioTherapeutics, Inc.



By:

/S/    DANIEL C.
MONTANOName:

Daniel C. MontanoTitle:

President and Chief Executive Officer




Date: November 4, 2005



I, Mickael A. Flaa, certify, pursuant to
18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report of CardioVascular BioTherapeutics, Inc. on Form 10-Q for the period ended September 30, 2005 fully complies with
the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in such Quarterly Report on Form 10-Q fairly presents in all material respects the financial condition and results of operations of
CardioVascular BioTherapeutics, Inc.



By:

/S/    MICKAEL A.
FLAAName:

Mickael A. FlaaTitle:

Chief Financial Officer




Date: November 4, 2005
Antonio R. REYNOLDS, Appellant, v. STATE of Florida, Appellee.

Case No. 5D18-2694

District Court of Appeal of Florida, Fifth District.

Decision filed April 9, 2019 Rehearing Denied May 15, 2019

**DECISION WITHOUT PUBLISHED OPINION**

AFFIRMED.
Case 3:05-cr-00302-EMC   Document 16   Filed 10/18/06   Page 1 of 2

Case 3:05-cr-00302-EMC   Document 16   Filed 10/18/06   Page 2 of 2
#### Jorge HERNANDEZ-MALDONADO, Petitioner, v. John ASHCROFT, Attorney General, Respondent.

No. 02-71991.

Agency No. [ AXX-XXX-XXX ].

United States Court of Appeals, Ninth Circuit.

Submitted May 10, 2004.*

Decided May 18, 2004.

Karla Kraus, San Diego, CA, for Petitioner.

Regional Counsel, Western Region Immigration & Naturalization Service, Laguna Niguel, CA, District Counsel, Office of the District Counsel, Department of Homeland Security, Executive Office of Immigration Review, Office of Immigration Judge, San Diego, CA, Ronald E. LeFevre, Chief Legal Officer, Office of the District Counsel, Department of Homeland Security, San Francisco, CA, Linda S. Wendtland, Esq., Ann Carroll Yarnon, Esq., U.S. Department of Justice, for Respondent.

Before CANBY, KOZINSKI, and PAEZ, Circuit Judges.

*

 The panel unanimously finds this case suitable for decision without oral argument. *See*Fed. R.App. P. 34(a)(2).

*566MEMORANDUM **

Jorge Hernandez-Maidonado, a native and citizen of Mexico, petitions for review of the Board of Immigration Appeals’ (“BIA”) three-judge order denying his motion to reopen or reconsider its previous summary affirmance of the immigration judge’s denial of his application for cancellation of removal. We dismiss the petition for review.

Pursuant to this Court’s December 26, 2002 order, which limited the issues on appeal to the BIA’s June 6, 2002 order denying Petitioner’s motion to reopen or reconsider, we lack jurisdiction to consider Petitioner’s contentions regarding the BIA’s April 5, 2002 decision.

We also lack jurisdiction to review the BIA’s June 6, 2002 denial of Petitioner’s motion to reopen or reconsider because this Court is barred from reviewing the BIA’s judgment regarding the granting of discretionary relief of cancellation of removal. *See 8*U.S.C. § 1252(a)(2)(B)(i); *cf. Medina-Morales v. Ashcroft,*362 F.3d 1263, 1267-69 (9th Cir.2004) (finding jurisdiction to review denial of motion to reopen where BIA had never ruled on the discretionary relief sought by Petitioner).

Pursuant to *Desta v. Ashcroft,*365 F.3d 741 (9th Cir.2004), Petitioner’s motion for stay of removal included a timely request for stay of voluntary departure. Because the motion for stay of removal was granted, the voluntary departure period was also stayed, nunc pro tunc, to the filing of the motion for stay of removal and this stay will expire upon issuance of the mandate.

PETITION FOR REVIEW DISMISSED.

**

**This disposition is not appropriate for publication and may not be cited to or by the courts of this circuit except as provided by Ninth Circuit Rule 36-3.
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Quarterly Report of Golden West Brewing Company, Inc., (the "Company") on Form 10-QSB for the period ended June 30, 2007, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, John C. Power, Chief Executive Officer, Chief Financial Officer, Principal Executive Officer and Principal Accounting Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that: (1)The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and(2)The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.   /s/ John C. Power______________ John C. Power, Chief Executive Officer, Chief Financial Officer, Principal Executive Officer and Principal Accounting Officer August 14, 2007
June 30, 2020 December 31, 2019

Assets

Cash and Cash Equivalents 1,930,880,348 $             103,408,185 $               

Investments in U.S. Treasury Obligations 3,227,765,304                  4,853,235,198               

Accrued Interest Receivable 16,118,537                      22,178,347                     

Premium Receivable 105,763,977                   222,676,000                  

Other Receivables

Prepaid Expenses

General Property, Equipment, and Software, Net 34,286                             43,717                            

Total Assets 5,280,562,452 $             5,201,541,447 $            

Liabilities and Insurance Fund

Accounts Payable and Accrued Expenses 510,304 $                        529,586 $                       

Farm Credit Insurance Fund

     Unallocated Insurance Fund Balance 5,280,052,148                5,138,297,620               

Allocated Insurance Fund Balance 62,714,241                     

Total Insurance Fund 5,280,052,148 $             5,201,011,861 $            

Total Liabilities and Insurance Fund 5,280,562,452 $             5,201,541,447 $            

June 30, 2020 and December 31, 2019

Farm Credit System Insurance Corporation

Comparative Statement of Financial Condition

(Unaudited)
Calendar Year to Date Calendar Year to Date

June 30, 2020 June 30, 2019

Income

Premiums 105,763,976 $                114,240,000 $               

Interest Income on Investments 38,015,637                      46,079,124                     

Total Income 143,779,613 $                160,319,124 $               

Expenses

Administrative Operating Expenses 2,025,085 $                     1,981,623 $                    

$                    1,981,623 2,025,085 $                   

Net Income 141,754,528 $                158,337,501 $               

Balance at January 1, 2020 $            5,201,011,861

Payment to AIRAs Accountholders (62,714,241)                   

Net Income 141,754,528                  

Balance at June 30, 2020 5,280,052,148 $            

(Unaudited)

Farm Credit System Insurance Corporation

Comparative Statement of Revenue and Expense

Period Ended June 30, 2020 and June 30, 2019

Statement of Changes in Insurance Fund

Period Ended June 30, 2020

(Unaudited)
EXHIBIT 32.1



CERTIFICATION PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF
2002



In connection with the Annual Report of
XsunX, Inc. (the “Company”) on Form 10-K for the fiscal year ended September 30, 2011 as filed with the U.S.
Securities and Exchange Commission on the date himself (the “Report”), the undersigned hereby certifies pursuant
to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to his knowledge:



1.     The Report fully complies with the
requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and



2.     The information contained in the
Report fairly presents, in all material respects, the financial condition and results of operation of the Company.



Date:     December 29, 2011



|/s/  Tom Djokovich                                                                                                                       
|-----------------------------------------------------------------------------------------------------------------------------------------
|Name: Tom Djokovich                                                                                                                      
|Title: Chief Executive Officer, Principal Executive
        Officer, and Principal Financial and
        Accounting Officer, and Director



A signed original of this written statement
required by Section 906, or other document authentications, acknowledging, or otherwise adopting the signature that appears in
typed form within the electronic version of this written statement required by Section 906, has been provided to the Company and
will be retained by the Company and furnished to the U.S. Securities and Exchange Commission or its staff upon request.
III 

117TH CONGRESS 

2D SESSION S. CON. RES. 45 

Providing for a correction in the enrollment of H.R. 6833. 

IN THE SENATE OF THE UNITED STATES 

SEPTEMBER 29, 2022 

Mr. LEAHY submitted the following concurrent resolution; which was 

considered and agreed to 

CONCURRENT RESOLUTION 

Providing for a correction in the enrollment of H.R. 6833. 

1 Resolved by the Senate (the House of Representatives 

2 concurring), That, in the enrollment of H.R. 6833, the 

3 Clerk of the House of Representatives shall amend the 

4 title so as to read: ‘‘Making continuing appropriations for 

5 fiscal year 2023, and for other purposes.’’. 


kjohnson on DSK79L0C42PROD with BILLS
* Pursuant to Local Rule 47.5, the court has determined that

this opinion should not be published and is not precedent except

under the limited circumstances set forth in Local Rule 47.5.4.

IN THE UNITED STATES COURT OF APPEALS

FOR THE FIFTH CIRCUIT

_____________________

No. 95-30883

_____________________

VINCENT LaPRIME,

Plaintiff-Appellant,

versus

DR. PALLAZZO, ET AL.,

Defendants,

DAVID WALTERS, JR., Deputy,

Defendant-Appellee.

_________________________________________________________________

Appeal from the United States District Court for the

Eastern District of Louisiana

(94-CV-3130-F)

_________________________________________________________________

October 9, 1996

Before REYNALDO G. GARZA, JOLLY, and DeMOSS, Circuit Judges.

PER CURIAM: *

Vincent LaPrime filed an action under 42 U.S.C. § 1983 against

Deputy David Walters, Jr. and others, alleging that W alters had

injured LaPrime’s wrist by using excessive force whil e trying to

handcuff LaPr ime. A key issue at trial was whether LaPrime had

reacted violently to Walters’ initial attempt to handcuff him. Thedistrict cou rt admitted the testimony of Dr. Richard Richoux, a

psychiatrist who had previously treated LaPrime while LaPrime was

incarcerated in a prison psychiatric ward. Dr. Richoux testified

that LaPrime su ffers from anti-social personality disorder, and

that manipulative behavior and aggressive r eactions to authority

figures are typical of that disease. LaPrime appeals the jury

verdict against hi m, arguing that Richoux’s testimony was

inadmissible character evidence under Fed. R. Evid. 404(a).

Rule 404(a) states generally that “[e]vidence of a person’s

character or a trait of character is not admissible for the purpose

of proving action in conformity therewith

. . .” The Federal Rules

of Evidence do not define the term “character trait.” Other courts

and authorities, however, have concluded that a character trait is

“an element of one’s disposition.” S ee United States v. West

, 670

F.2d 675, 682 (7th Cir. 1982) (holding that “limited intelligence”

was not a character trait).

Having considered these authorities and the arguments of the

parties, we conclude that Dr. Richoux’s testimony, concerning the

mental disease with which LaPrime had been diagnosed, was properly

admitted as expert medical opinion that would assist the jury in

determining a disputed issue of fact. Fed.R.Evid. 702. Accordingly, the judgment of the district court is

A F F I R M E D.
QUANTUM RESOURCES MANAGEMENT, L.L.C., and Milagro Producing, L.L.C v. PIRATE LAKE OIL CORP., et al

NO. 2019-C-0487

Supreme Court of Louisiana.

May 20, 2019

Denied.
Mark PALETTI and Tim Paletti, Appellants, v. KEARNS HOLDINGS, LLC and Dane Gilbert, Appellees.

No. 1D17-5358

District Court of Appeal of Florida, First District.

April 8, 2019 Rehearing Denied May 30, 2019

**DECISION WITHOUT PUBLISHED OPINION**

AFFIRMED.
Case 3:06-cv-00081-B Document 46 Filed 09/01/06 Page 1 of 1 PageID 530